Amgen increases outlook after surprisingly high quarterly profit
THOUSAND OAKS (dpa-AFX) – The US biotech group Amgen is more optimistic about developments in the current year. Adjusted earnings per share (EPS) should be between $ 16.50 and $ 17.10, the company said on Tuesday after the US market closed. Previously, Amgen had assumed $ 16-17. In the third quarter, EPS was up 11 percent year-on-year to $ 4.67. Analysts had only expected $ 4.27.
Sales increased by 4 percent to $ 6.7 billion. That roughly corresponded to the expectations of experts. Falling prices for some drugs were more than offset by strong increases in sales.
Amgen’s share price recently fell by one and a half percent. Since the beginning of the year, the minus has even been almost seven percent./he